Buyung Poetra Sembada Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Buyung Poetra Sembada Tbk. trades at Rp53 (market cap 512.92B, 480.8K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp250 (market cap 167.37B, 23.1K 24h volume). The key difference: Buyung Poetra Sembada Tbk. is far larger — about 3.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Buyung Poetra Sembada Tbk. is more actively traded (480.8K versus 23.1K). Which is the better fit depends on your goals.
| HOKI | OBAT | |
|---|---|---|
Market Cap | 512.92B | 167.37B |
Volume | 480.8K | 23.1K |
Lot | 4.81K | 231 |
Turnover | 25.53M | 5.7M |
Average Price | 53.1 | 246.93 |
Value | 25.53M | 5.7M |
Indicative Equilibrium Price | 53 | 246 |
Indicative Equilibrium Volume | 164K | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Buyung Poetra Sembada Tbk (the “Company”) was established based on Notarial Deed No. 46 ofIchsan Tedjabuana, S.H., dated September 16, 2003.
Read more on HOKI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →